Assessment of response to treatment in anemia (iron deficiency) after CABG in adults
Phase 3
Recruiting
- Conditions
- Chronic ischemic heart disease.Chronic ischemic heart disease
- Registration Number
- IRCT20170912036157N2
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 142
Inclusion Criteria
Age between 18 until 72 years
Patients are candidates for CABG for the first time
Hemoglobin is less than 10 in women and less than 11 in men
Exclusion Criteria
History of previous surgery
Kidney disorders
Autoimmune diseases
Bleeding disorders,
Thalassemia
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hemoglobin level. Timepoint: Before and after treatment. Method of measurement: Blood test.
- Secondary Outcome Measures
Name Time Method Ferritin level. Timepoint: Before and after treatment. Method of measurement: blood test.